Papuloerythroderma of Ofuji: A first case report from Indonesia

(1)

Journal of General - Procedural Dermatology & Venereology Journal of General - Procedural Dermatology & Venereology Indonesia

Indonesia

Volume 1

Number 3 December Article 3

12-31-2016

Papuloerythroderma of Ofuji: A first case report from Indonesia Papuloerythroderma of Ofuji: A first case report from Indonesia

Graciella Regina

Department of Dermatology and Venereology, Faculty of Medicine Universitas Gadjah Mada/ dr. Sardjito General Hospital, Yogyakarta, Indonesia

Listya Paramita

Sunard Radiono

Yohanes Widodo Wirohadidjojo

William R. Faber

Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Follow this and additional works at: https://scholarhub.ui.ac.id/jdvi

Part of the Dermatology Commons, Integumentary System Commons, and the Skin and Connective Tissue Diseases Commons

Recommended Citation Recommended Citation

Regina, Graciella; Paramita, Listya; Radiono, Sunard; Wirohadidjojo, Yohanes Widodo; and Faber, William R.

(2016) "Papuloerythroderma of Ofuji: A first case report from Indonesia," Journal of General - Procedural Dermatology & Venereology Indonesia: Vol. 1: No. 3, Article 3.

DOI: 10.19100/jdvi.v1i3.28

Available at: https://scholarhub.ui.ac.id/jdvi/vol1/iss3/3

This Article is brought to you for free and open access by UI Scholars Hub. It has been accepted for inclusion in Journal of General - Procedural Dermatology & Venereology Indonesia by an authorized editor of UI Scholars Hub.

(2)

J Gen Pro DVI. 2016;1(3):93-8 93 Case report

Papuloerythroderma of Ofuji in Indonesia:

the first case report

Graciella Regina, Listya Paramita, Sunardi Radiono, Yohanes Widodo Wirohadidjojo, William R Faber*

Department of Dermatology and Venereology, Faculty of Medicine Universitas Gadjah Mada/

dr. Sardjito General Hospital, Yogyakarta, Indonesia

*Department of Dermatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands

Email: graciella.regina@gmail.com

Abstract

Papuloerythroderma (PE) is a rare skin disease which was first described by Ofuji et al. in 1984, with a typical sign that the lesions spare the large cutaneous folds, known as the deck chair sign. Due to its recent identification, this disease is still underrecognized and may lead to misdiagnosis. We reported the first case report of PE of Ofuji from Indonesia in which the diagnosis was delayed for two years. Besides the deck chair sign in the large cutaneous fold, we also found that the area between and above his eyebrows that was relatively spared in contrast to the sparing of the cutaneous folds, and it may be considered as pseudo-deck chair sign. The patient showed good response with combination therapy of phototherapy with Narrow-Band Ultraviolet B (NBUVB), oral methotrexate, and corticosteroids. The deck chair sign disappeared after six months therapy, but the patient’s skin was still xerotic.

Key words: Papuloerythroderma of Ofuji, deck chair sign, pseudo-deck chair sign

Abstrak

Papuloeritroderma (PE) adalah penyakit kulit yang jarang ditemukan, yang dideskripsikan pertama kali oleh Ofuji et al. pada tahun 1984. Karakteristik klinis yang khas dari PE adalah lipatan kulit besar yang bebas lesi, dan dikenal sebagai deck chair sign. Penyakit ini masih kurang dikenali karena baru diidentifikasi, sehingga dapat menyebabkan kesalahan diagnosis. Kami melaporkan sebuah kasus pertama PE of Ofuji dari Indonesia yang baru terdiagnosis setelah penyakitnya berlangsung selama dua tahun. Selain deck chair sign pada lipatan kulit besar, kami juga menemukan bahwa area di antara dan di atas alis pasien relatif bebas lesi, dan dapat dipertimbangkan sebagai pseudo-deck chair sign. Pasien menunjukkan respons yang baik dengan terapi kombinasi menggunakan fototerapi Narrow-Band Ultraviolet B (NBUVB), methotrexate oral, dan kortikosteroid oral. Lesi deck chair sign menghilang setelah pasien mendapat terapi kombinasi selama enam bulan, namun kulit pasien masih tampak kering dan bersisik.

Kata kunci: Papuloeritroderma Ofuji, deck chair sign, pseudo-deck chair sign

Introduction

Papuloerythroderma (PE) is a rare, well- characterized skin disease, first described by Ofuji et al.in 1984.¹ PE mostly affects elderly men.

Reports show association of PE with malignancy in 21.76% of patients, atopic dermatitis in 9.23%

of patients, and drug-induced hypersensitivity in

less than 5% of patients.^2-4It is characterized by a widespread eruption of intense pruritic papules which later coalesce to form plaques, and potentiallyevolve into erythroderma. The typical sign of PE is the free lesions of large cutaneous folds, which is known as the deck chair sign.⁵ Bech and Thomsen⁶ found an annual incidence of 1.5 per million over ten years observation.⁶

(3)

J Gen Pro DVI. 2016;1(3):93-8 94 However, poor awareness among dermatologists,

may underlie the fact that PE is still underrecognized, underdiagnosed, and underreported.⁴ To the authors’ knowledge, this is the first case report of PE in Indonesia.

Report

A 62-year old male, diagnosed as exfoliative dermatitis caused by seborrheic dermatitis was referred to the outpatient Department of Dermatology and Venereology, dr. Sardjito General Hospital Yogyakarta. There was a 2-year history of itchy skin lesions. It started as multiple itchy red papules on both thighs, which then eventually distributed to cover almost full body surface. He then visited a dermatovenereologist.

Initially, the diagnosis was exfoliative dermatitis.

He received oral corticosteroid, antihistamines, topical corticosteroids, and emollients for 2 weeks.

His symptoms were responsive to the therapy but recurred after the treatment finished. A skin biopsy was performed one year after the first visit.

The pathology result suggested exfoliative dermatitis with seborrheic dermatitis. He then received the treatment as mentioned above for another two weeks.

A month before he came to our clinic his skin condition worsened. He was hospitalized in a district hospital for a week. At the time of hospital discharge, the treatment were oral antihistamines, topical corticosteroids, and olive oil. The itch severity decreased and his skin became hyperpigmented. He took this treatment for three weeks, but the symptoms recurred two days after the medication was stopped.

The patient denied any drug consumption prior to the skin eruption. There was no history of a prolonged cough, gastrointestinal tract complaints, or rapid weight loss. No risk for HIV infection was found.

On examination the patient’s vital signs were within normal limits. There were multiple brown, flat-topped scally papules covering his trunk and extremities. The abdominal and cubital folds were free of lesions (Figure 1). There were flat-topped papules on the cheeks and infiltration in the forehead with prominent skin lines. The area between and above his eyebrows was relatively free of lesions (Figure 2). No lesions were found on his scalp. The distribution of the lesion did not correspond to the Langer’s lines. There were smooth, circumscribed lymph nodes in his left axilla and right inguinal fold.

Peripheral blood examination showed mild leucocytosis with absolute neutrophilia (9.060 cells/µl). Lymphocyte, eosinophil, erythrocyte, and platelet counts were normal. Haemoglobin, hematocrit, transaminase enzymes, blood urea nitrogen, and immunoglobulin E (IgE) were within normal limits. No Sezary cells were found.

Histopathological examination taken from patient’s left arm stained with hematoxylin eosin revealed orthokeratosis, flattening of rete ridges, and focal spongiosis in the epidermis with lymphocyte infiltration. In the upper dermis, there were lymphocytes and histiocytes patchy infiltrates with sparse eosinophils, and edema. (Figure 3). The conclusion was spongiotic dermatitis, compatible with PE. The immunohistochemistry staining showed CD 45+ and CD3+ cell infiltrates in the dermis and epidermis, which may indicate a T-cell origin of the infiltrates.

The patient was diagnosed with primary PE and treatment was started with a combined therapy of daily 16 mg oral methylprednisolone and weekly 10 mg methotrexate, and phototherapy with Narrowband Ultraviolet B (NBUVB). The NBUVB therapy was conducted twice a week, and was started from 500mJ/cm²to increase 25% after every three sessions. After three weeks of the combined therapy, the itch intensity lessened and the papules flattened, but xerotic scaly skin and the deck chair sign was still visible. After six months of treatment, the scaly xerotic skin was still present but the deck chair sign had disappeared (Figure 4).

Discussion

Classical PE of Ofuji has typical clinical manifestations of generalized pruritic eruption mimicking erythroderma with itchy flat-topped papules which coalesce generally. The lesions spare large skin folds and pressure areas, and this is known as the deck chair sign. Besides the typical skin lesions appearance, in PE, lymphadenopathy, palmoplantar keratoderma, and nail infarcts may also be present.²

The patient had a history of chronic itch and redness covering his entire skin with multiple brown flat-topped papules which spared his abdominal and cubital folds. There was also lymphadenopathy found.

Torchia et al.⁴ in their review, mentioned that face and scalp are seldom involved.⁴In our patient, the lesions were also found on his face.

(4)

J Gen Pro DVI. 2016;1(3):93-8 95 Figure 1. Abdominal and cubital folds were lesions free, which is known as a deck chair sign. There was cobblestone appearance of the lesional skin.

Figure 2. The area between and above his eyebrows was relatively free of lesions. We propose to identify this as a pseudo-deck chair sign.

(5)

J Gen Pro DVI. 2016;1(3):93-8 96 Figure 3. Histopathology examination with hematoxylin eosin staining (x400) showed spongiotic epidermis with lymphocytes and histiocytes infiltrate in the upper dermis, concluded as spongiotic dermatitis.

Figure 4. Patient’s skin condition after six months of treatment. Xerotic and scaly skin, the deck chair sign on the abdominal skin disappeared.

(6)

J Gen Pro DVI. 2016;1(3):93-8 97 Moreover, the area between and above his

eyebrows was relatively free of lesions. We propose this phenomenon to be considered as a pseudo-deck chair sign (Figure 2), as it is in contrast to the sparing of the cutaneous folds.

Laboratory results of PE patients revealed eosinophilia in 85% of patients, low lymphocyte count in 29% of patient, and an increase in IgE serum level in 50% of patients.^2,4None of these was found in our patient.

Histopathologic examination from the skin lesion of PE is not characteristic. In the epidermis hyperkeratosis, acanthosis, and focal spongiosis, in the dermis perivascular infiltrates consisting mostly of lymphocytes, plasma cells, histiocytes, and eosinophils.⁷ In our patient, the histopathological result was compatible with PE.

Torchia et al.⁴ classified PE according to its etiology. Primary PE is when the underlying cause is unknown. Secondary PE is referred to PE that is associated with atopic dermatitis, malignancy, infection, or drug-induced. In cutaneous T-cell lymphoma (CTCL) like PE, the patients have PE clinically, but their histopathology results fit CTCL.

Pseudopapuloerythroderma is a condition of an erythroderma without papules but featuring a deck chair sign on the large skin folds, like those found in PE.⁴Our patient fitted the primary PE, because we could not find any underlying disease related to PE, and there were no Pautrier’s abscess nor cerebri form lymphocytes in histopathology examination.

Torchia, et al.⁴also reported that the median duration of the skin rash at the time of diagnosis was seven months. Before the patient was referred to our hospital, he was diagnosed as having exfoliative dermatitis, a disease characterized by erythema scaly skin involving more than 90% of the body surface.⁸ Initial misdiagnosed by a dermatologist resulted in 2 years delayed diagnoses, longer than the average delayed time suggested by Torchia et al.⁴

The skin areas without lesions may lead clinicians to make a differential diagnosis of pityriasis rubra pilaris (PRP). PRP is a papulosquamous disorder with follicular hyperkeratotic papules, palmoplantar keratoderma, and widespread orange-red erythema with islands of skin without lesions.⁹ The histopathology of PRP shows hyperkeratosis with alternating orthokeratosis and parakeratosis, hypergranulosis, and a perivascular lymphocytic dermal infiltrate.^9,10 Our patient did not have follicular hyperkeratotic skin lesions, palmoplantar keratoderma, and the skin

lesions were not orange-red in color. The histopathology did not show any alternating, orthokeratosis and parakeratosis; thus the diagnosis of PRP can be excluded.

Bech-Thomsen and Thomsen⁶ reported improvement of PE cases treated with systemic corticosteroids, phototherapy with UVA (PUVA), combination therapy of PUVA with systemic corticosteroids or phototherapy with UVB in combination with potent topical corticosteroids.⁶ The itch severity and papules redness of our patient improved after receiving combination therapy of NBUVB, oral methotrexate, and oral corticosteroids for three weeks. Six months after this treatment combination, the scaly xerotic skin was still present but the deck chair sign had disappeared.

Conclusion

Papulo-erythroderma of Ofuji is a rare skin disease with clinical characteristic known as the deck chair sign. In our case, there were two years of diagnosis delay since the onset of the disease.

The skin condition showed a good response to combination therapy of NBUVB, oral methotrexate, and oral corticosteroid.

Acknowledgement

None

References

1. Ofuji S, Furukawa F, Miyachi Y, Ohno S.

Papuloerythroderma. Dermatologica.

1984;169:125-30.

2. Mathew M, Nayal B, Unni RN, Balachandaran C. Papuloerythroderma of Ofuji in a young adult. J Interdiscipl Histopathol. 2014;2:38-40.

3. Pereiro M Jr, Sanchez-Aguilar D, Pereiro Ferreiros MM, Amrouni B, Toribio J.

Cutaneous T-cell lymphoma: an expression of papuloerythroderma of Ofuji. J Eur Acad Dermatol Venereol. 2003;17:227-49.

4. Torchia D, Miteva M, Hu S, Cohen C, Romanelli P. Papuloerythroderma 2009: Two new cases and systematic review of the worldwide literature 25 years after its identification by Ofuji et al. Dermatology.

2010;220:311-20.

5. Hassan I, Ahmad M, Manaan Q, Hussain S, Masood Q. Papuloerythroderma of Ofuji – a case report. J Pak Assoc Derma.

2013;23:103-5.

(7)

J Gen Pro DVI. 2016;1(3):93-8 98 6. Bech-Thomsen N, Thomsen K. Ofuji’s

papuloerythroderma: A study of 17 cases.

Clin Exp Dermatol. 1998;23:79-83.

7. Bettoli V, Pizzigoni S, Borghi A. Ofuji papuloerythroderma: A reappraisal of the deck-chair sign. Dermatology. 2004;209:1-4.

8. Okoduwa C, Lambert WC, Schwartz RA, Kubeyinje E, Eitokpah A, Sinha S, et al.

Erythroderma: Review of potentially life- threathening dermatosis. Indian J Dermatol.

2009;54:1-6.

9. Petrof G, Almaani N, Archer CB, Griffiths WA, Smith CH. A systematic review of the literature on the treatment of pityriasis rubra pilaris type 1 with TNF-antagonists. J Eur Acad Dermatol Venereol. 2013;27:e131-5.

10. Chan H, Liu FT, Naguwa S. A review of pityriasis rubra pilaris and rheumatologic association. Clin Develop Immunol.

2004;11:57-60.